Scage Future
SCAG Nasdaq Truck & Bus Bodies Financials FY2023–FY2025
What Scage Future does
No business description yet.
- Legal name
- Scage Future
- Fiscal year ends
- June 30, 2025
- Latest annual report
- 20-F · Nov 12, 2025
- Accession · CIK
- 0001213900-25-109190
0002000366
Revenue and margins
Scage Future had $11.1M of revenue in fiscal 2025, up 82.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$5.9M in fiscal 2025, −53.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Scage Future returned — to shareholders in fiscal 2025. The diluted share count rose 42.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Scage Future can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $0.2M | $2.0M | $0.1M |
| Debt incl. finance leases | — | $8.4M | $9.6M |
| Interest coverage | −44.4x | −15.9x | −39.7x |
| Current ratio | — | 0.7x | 0.2x |
| Quick ratio | — | 0.5x | 0.2x |
| Total assets | — | $10.6M | $26.5M |
| Total liabilities | — | $12.8M | $27.4M |
| Shareholders' equity | −$18.6M | −$26.0M | −$5.3M |
| Net debt (− = net cash) | — | $6.4M | $9.5M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ | ✕ |
| Return on assets rose | — | — | ✓ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ |
| Debt fell relative to assets | — | — | ✓ |
| Current ratio rose | — | — | ✕ |
| Share count didn't rise | — | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ |
| Revenue rose relative to assets | — | — | ✕ |
| F-score | — / 3 | — / 5 | 3 / 9 |
| Accruals ratio | — | 3.9% | −38.1% |
| Altman Z'' | — | −16.87 | −13.61 |
3 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $0.4M | $6.1M | $11.1M |
| Gross profit | −$0.4M | $0.5M | −$0.7M |
| Research and development | $2.3M | $1.7M | $1.5M |
| Operating income | −$6.7M | −$5.9M | −$13.4M |
| Interest expense | $0.2M | $0.4M | $0.3M |
| Pretax income | −$6.6M | −$6.0M | −$13.1M |
| Net income | −$6.4M | −$5.8M | −$12.9M |
| Net income to common | −$9.6M | −$7.7M | −$12.9M |
| Diluted EPS | −$0.19 | −$0.15 | −$0.18 |
| Diluted shares | 0.05B | 0.05B | 0.07B |
| Cash flow | |||
| Cash from operations | −$4.9M | −$6.2M | −$5.9M |
| Capital expenditure | $0.2M | $0.1M | $0.0M |
| Free cash flow | −$5.1M | −$6.3M | −$5.9M |
| Depreciation and amortization | $0.4M | $0.5M | $0.3M |
| Stock-based compensation | — | — | $1.8M |
| Balance sheet | |||
| Cash and short-term investments | $0.2M | $2.0M | $0.1M |
| Total debt | — | $8.4M | $9.6M |
| Deposits | — | $0.3M | $0.0M |
| Current assets | — | $8.6M | $5.0M |
| Current liabilities | — | $12.7M | $25.4M |
| Inventory | — | $1.7M | $1.0M |
| Property and equipment, net | — | $1.1M | $0.7M |
| Total assets | — | $10.6M | $26.5M |
| Total liabilities | — | $12.8M | $27.4M |
| Shareholders' equity | −$18.6M | −$26.0M | −$5.3M |
| Margins | |||
| Gross margin | −81.6% | 8.8% | −6.4% |
| Operating margin | −1,534.1% | −96.1% | −120.6% |
| EBITDA margin | −1,432.2% | −87.3% | −117.9% |
| Net margin | −1,469.7% | −95.1% | −116.4% |
| FCF margin | −1,155.0% | −102.7% | −53.1% |
| Returns | |||
| Return on capital | — | — | −248.0% |
| Return on capital employed | — | 276.3% | −1,246.7% |
| Return on assets | — | −55.1% | −69.9% |
| Growth | |||
| Revenue growth | — | 1,295.2% | 82.0% |
| Share count change | — | 0.0% | 42.4% |
| Financial health | |||
| Interest coverage | −44.4x | −15.9x | −39.7x |
| Current ratio | — | 0.7x | 0.2x |
| Quick ratio | — | 0.5x | 0.2x |
| Capital allocation | |||
| Capex / revenue | 37.9% | 0.8% | 0.1% |
| Stock comp / revenue | — | — | 16.2% |
| Quality scores | |||
| Piotroski F-score | — | — | 3.0 |
| Altman Z'' | — | −16.9 | −13.6 |
| Accruals ratio | — | 3.9% | −38.1% |
Source: SEC EDGAR XBRL filings (CIK 0002000366). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.